Events
Traditional quality assurance (QA) review of bioanalytical studies is often tied to predefined milestones and study deliverables, which can allow significant laboratory work to occur before potential issues are identified. This presentation explores a proactive QA model in which review is automatically initiated after a predefined number of laboratory batches. Through a case study, it will demonstrate how scheduled QA review can enable earlier issue detection, reduce operational and compliance risk, and improve overall quality performance. This approach may also enhance laboratory efficiency by addressing potential concerns before they affect subsequent work.
Presented by Katherine Yahvah, PhD, Laboratory Director
Moderated by Jera Kantz, Quality Assurance Manager
Wednesday, November 18, 2026
1:15 PM ET
"*" indicates required fields